Nuvation Bio Inc
Biotechnology
Healthcare
NUVB
341 M shares
NYSE US
traded
23 Sep 2025
listed
no
open
3.26
52 week high
3.90
high
3.30
52 week low
0.00
low
3.17
growth
15.00 %
previous Close
3.27
P/E ratio
market cap
787 M
div yield
0
usd
Jun 2025
qoq
revenue
4.83 M
56.71 %
net incoming
-59.01 M
-10.84 %
eps
0.00 %
-26.87 %
eps surprise
0.00 %
net profit margin
-1220.92 %
505.00 %
operating incoming
-63.59 M
-7.77 %
net change in cash
0.00 %
cash on hand
248 M
416.85 %
cost of revenue
2.58 M
23.02 %
top top